STMN2 and cancer: Within the Braun cohort, we evaluated the AUC of pan-cancer STMN2.SIG, several clinical variables, and the nomogram model, emphasizing pan-cancer STMN2.SIG’s superior predictive power (Supplementary Figure S7F).